Middle East Healthcare Company (4009.SR)
SAR 71.8
(2.28%)
SAR 71.8
(2.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.65 Billion | 2.15 Billion | 1.87 Billion | 1.77 Billion | 1.49 Billion | 1.39 Billion |
| Cost of Revenue | 1.68 Billion | 1.47 Billion | 1.26 Billion | 1.17 Billion | 1.02 Billion | 889.94 Million |
| Gross Profit | 971.77 Million | 680 Million | 608.18 Million | 599.99 Million | 472.93 Million | 500.74 Million |
| Operating Expenses | 661.23 Million | 535.15 Million | 545.57 Million | 470.26 Million | 367.73 Million | -338.01 Million |
| Selling, General and Administrative Expenses | 661.23 Million | 114.35 Million | 148.37 Million | 118.65 Million | 68.74 Million | 324.13 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 420.8 Million | 397.2 Million | 351.61 Million | 298.98 Million | -338.01 Million |
| Cost and Expenses | 2.31 Billion | 2 Billion | 1.81 Billion | 1.64 Billion | 1.39 Billion | 889.94 Million |
| Operating Income | 342.49 Million | 140.34 Million | 54.24 Million | 126.4 Million | 103.26 Million | 162.73 Million |
| Interest Expense | 153.17 Million | 65.98 Million | 41.52 Million | 31.11 Million | 20.02 Million | 11.1 Million |
| Income Tax Expense | 17.98 Million | 9.61 Million | 7.5 Million | 5.5 Million | 5.17 Million | 6.09 Million |
| Earnings before Tax | 201.61 Million | 81.21 Million | 19.23 Million | 99.67 Million | 95.28 Million | 170.66 Million |
| Net Income | 180.17 Million | 75.18 Million | 11.73 Million | 81.99 Million | 97.56 Million | 172.24 Million |
| Earnings Per Share Basic | 1.96 | 0.82 | 0.13 | 0.89 | 1.06 | 1.87 |
| Earnings Per Share Diluted | 1.96 | 0.82 | 0.13 | 0.89 | 1.06 | 1.87 |
| Weighted Average Shares Outstanding | 92.04 Million | 92.04 Million | 92.04 Million | 92.04 Million | 92.04 Million | 92.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 92.04 Million | 92.04 Million | 92.04 Million | 92.04 Million | 92.04 Million | 92.04 Million |
| Gross Margin | 0.37 | 0.32 | 0.32 | 0.34 | 0.32 | 0.36 |
| EBIT Margin | 0.21 | 0.14 | 0.11 | 0.15 | 0.14 | 0.13 |
| Profit Margin | 0.07 | 0.03 | 0.01 | 0.05 | 0.07 | 0.12 |
| EBITDA | 551.23 Million | 297.41 Million | 212.89 Million | 243.82 Million | 220.73 Million | 251.68 Million |
| Earnings Before Tax Margin | 0.13 | 0.07 | 0.03 | 0.07 | 0.07 | 0.12 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 732.07 Million | 712.66 Million | 689.2 Million | 2.65 Billion | 719.81 Million | 671.04 Million |
| Cost of Revenue | 439.17 Million | 433.59 Million | 431.39 Million | 1.68 Billion | 426.95 Million | 404.72 Million |
| Gross Profit | 292.9 Million | 279.07 Million | 257.81 Million | 971.77 Million | 292.85 Million | 266.32 Million |
| Operating Expenses | 177.02 Million | 173.34 Million | 140.18 Million | 623.63 Million | 205.7 Million | 156.47 Million |
| Selling, General and Administrative Expenses | - | 173.33 Million | 140.18 Million | - | 205.7 Million | 156.47 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -177.02 Million | -173.34 Million | 7.73 Million | -520.97 Thousand | 4.84 Million | 4.07 Million |
| Cost and Expenses | 616.19 Million | 606.93 Million | 571.57 Million | 2.3 Billion | 632.65 Million | 561.19 Million |
| Operating Income | 115.88 Million | 105.73 Million | 117.63 Million | 348.14 Million | 87.15 Million | 109.85 Million |
| Interest Expense | - | 62.16 Million | 66.17 Million | 153.17 Million | 49.47 Million | 54.97 Million |
| Income Tax Expense | -61.74 Million | 7.26 Million | 7.22 Million | 17.98 Million | 3.93 Million | 4.72 Million |
| Earnings before Tax | - | 67.41 Million | 59.19 Million | 201.61 Million | 39.38 Million | 58.95 Million |
| Net Income | 61.74 Million | 61.17 Million | 51.94 Million | 180.17 Million | 36.5 Million | 53.3 Million |
| Earnings Per Share Basic | 0.67 | 0.66 | 0.56 | - | 0.40 | 0.58 |
| Earnings Per Share Diluted | 0.67 | 0.66 | 0.56 | - | 0.40 | 0.58 |
| Weighted Average Shares Outstanding | 92.03 Million | 92.04 Million | 92.04 Million | 92.04 Million | 92.04 Million | 92.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 92.03 Million | 92.04 Million | 92.04 Million | 92.04 Million | 92.04 Million | 92.04 Million |
| Gross Margin | 0.40 | 0.39 | 0.37 | 0.37 | 0.41 | 0.40 |
| EBIT Margin | 0.16 | 0.26 | 0.25 | - | 0.19 | 0.24 |
| Profit Margin | 0.08 | 0.09 | 0.08 | 0.07 | 0.05 | 0.08 |
| EBITDA | 115.88 Million | 182.85 Million | 168.96 Million | - | 136.75 Million | 159.33 Million |
| Earnings Before Tax Margin | 0.16 | 0.15 | 0.17 | 0.13 | 0.12 | 0.16 |
6573
GRAMMY
BNDSY
SOMANYCERA
4570
INPOY